Methods and compositions for quantifying hemoglobin

Inventors

Xu, Weidong

Assignees

Cello Therapeutics Inc • Cellics Therapeutics Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-11353466-B2

Patent

Publication Date

2022-06-07

Expiration Date


Abstract

The present invention relates to methods and compositions for quantifying hemoglobin using, inter alia, a peroxidase substrate and hydrogen peroxide.

Core Innovation

The document describes a method for quantifying hemoglobin in a sample by contacting the sample with a peroxidase substrate and hydrogen peroxide, under suitable conditions, to form an oxidation product. The hemoglobin level is determined by assessing the peroxidase substrate and/or the oxidation product. The peroxidase substrate is oxidized by hydrogen peroxide to generate an oxidation product, including an example oxidation product identified as 7-hydroxyphenoxazin-3-one.

The sample analyzed in the method comprises a cellular membrane coated nanoparticle, where the nanoparticle includes an inner core comprising a non-cellular material and an outer surface comprising a cellular membrane derived from a hemoglobin-containing cell. The document describes this nanoparticle architecture in connection with hemoglobin-containing cellular membrane-coated nanoparticles, and the sample may further include a releasable cargo.

The disclosed peroxidase substrate and detection approach includes substrates and readouts such as ADHP and detection by colorimetric and/or fluorescent assessment of the oxidation product. The document further describes a kit/system configuration for quantifying hemoglobin that comprises the peroxidase substrate and hydrogen peroxide, and a solution or suspension having basic pH and/or containing a surfactant for preparing the sample.

Claims Coverage

The document includes two independent claims, one directed to a hemoglobin quantification method and one directed to a hemoglobin quantification kit. Across these independent claims, the inventive subject matter centers on a peroxidase substrate/hydrogen peroxide oxidation assay coupled to assessment of the oxidation product, and on using a specific sample type: a cellular membrane coated nanoparticle with a non-cellular inner core and a cellular membrane derived from a hemoglobin-containing cell. An additional independent-claim distinction is that the kit claim includes a solution or suspension with basic pH and/or surfactant as part of the kit components.

Peroxidase substrate oxidation and assessment for hemoglobin quantification

Contacting a sample containing or suspected of containing hemoglobin with a peroxidase substrate and hydrogen peroxide to form an oxidation product, and assessing the peroxidase substrate and/or the oxidation product to quantify hemoglobin.

Cellular membrane coated nanoparticle sample architecture

Using a sample that comprises a cellular membrane coated nanoparticle having an inner core comprising a non-cellular material and an outer surface comprising a cellular membrane derived from a hemoglobin-containing cell.

Kit components for hemoglobin quantification

Providing a kit comprising a peroxidase substrate and hydrogen peroxide, together with a solution or suspension having basic pH and/or containing a surfactant for preparing a sample.

Kit usage with cellular membrane coated nanoparticle

Wherein the sample in the kit context comprises a cellular membrane coated nanoparticle having an inner core comprising a non-cellular material and an outer surface comprising a cellular membrane derived from a hemoglobin-containing cell.

Overall claim coverage focuses on hemoglobin quantification via peroxidase-mediated oxidation (peroxidase substrate plus hydrogen peroxide with assessment of the substrate and/or oxidation product), and on performing the quantification on a cellular membrane coated nanoparticle sample defined by a non-cellular inner core and an outer cellular membrane derived from a hemoglobin-containing cell. The kit claim additionally requires inclusion of basic pH and/or surfactant-containing solution or suspension as part of the kit components.

Stated Advantages

Not explicitly described in patent.

Documented Applications

Not explicitly described in patent.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.